Thermo Fisher to acquire viral vector CDMO Brammer Bio for $1.7bn
(adsbygoogle = window.adsbygoogle || []).push({}); Global life sciences company Thermo Fisher Scientific has agreed to acquire Massachusetts-based Brammer Bio from Ampersand Capital Partners for about More...
Novartis wraps up $2.1bn acquisition of US biopharma company Endocyte
Pharma acquisition news : Swiss pharma giant Novartis has wrapped up its previously announced acquisition of US biopharma company Endocyte in a deal worth around $2.1 billion. Endocyte is engaged in the development More...
P&G completes €3.4bn acquisition of Merck’s consumer health business
US consumer goods company Procter & Gamble (P&G) has wrapped up its previously announced €3.4 billion acquisition of the consumer health business of German pharma company Merck. Procter & Gamble said More...
US biopharma company Endocyte to be acquired by Novartis for $2.1bn
Novartis acquisition of Endocyte : US biopharma company Endocyte has agreed to be acquired by Swiss pharma company Novartis in a deal worth around $2.1 billion. As per the latest pharma acquisition news, Novartis More...
Cambrex acquisition of Halo Pharma : US CDMO to be acquired for $425m
Cambrex acquisition of Halo Pharma : Cambrex has made a $425 million deal to buy US-based contract development and manufacturing organization (CDMO) Halo Pharma to gain entry into the large and finished dosage form More...
CVC to acquire €3.03bn worth stake in Italian pharma company Recordati
Pharma acquisition news : CVC Capital Partners through its CVC Fund VII has led a consortium of funds to acquire a stake of 51.8% in Recordati, an Italian pharma company in a deal worth around €3.03 billion. The More...
Lilly wraps up acquisition of immuno-oncology company Armo BioSciences
Pharma acquisition news : US pharma firm Eli Lilly and Company (Lilly) has completed its $1.6 billion acquisition of Armo BioSciences, a California-based late-stage immuno-oncology company. Armo BioSciences is focused More...
Novartis to buy nuclear medicine company Advanced Accelerator Applications
Pharma acquisition news : Novartis, the Switzerland-based global healthcare company will acquire Advanced Accelerator Applications (AAA), a French radiopharmaceutical company for a sum of $3.9 billion, in a move More...